Publications

BibTex format

@article{Dattani:2020:10.1177/0268355520936420,
author = {Dattani, N and Shalhoub, J and Nandhra, S and Lane, T and Abu-Own, A and Elbasty, A and Jones, A and Duncan, A and Garnham, A and Thapar, A and Murray, A and Baig, A and Saratzis, A and Sharif, A and Huasen, B and Dawkins, C and Nesbitt, C and Carradice, D and Morrow, D and Bosanquet, D and Kavanagh, E and Shaikh, F and Gosi, G and Ambler, G and Fulton, G and Singh, G and Travers, H and Moore, H and Olivier, J and Hitchman, L and O'Donohoe, M and Popplewell, M and Medani, M and Jenkins, M and Goh, MA and Lyons, O and McBride, O and Moxey, P and Stather, P and Burns, P and Forsythe, R and Sam, R and Brar, R and Brightwell, R and Benson, R and Onida, S and Paravastu, S and Lambracos, S and Vallabhaneni, SR and Walsh, S and Aktar, T and Moloney, T and Mzimba, Z and Nyamekye, I},
doi = {10.1177/0268355520936420},
journal = {Phlebology},
pages = {706--714},
title = {Reducing the risk of venous thromboembolism following superficial endovenous treatment: a UK and Republic of Ireland consensus study},
url = {http://dx.doi.org/10.1177/0268355520936420},
volume = {35},
year = {2020}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - ObjectivesVenous thromboembolism is a potentially fatal complication of superficial endovenous treatment. Proper risk assessment and thromboprophylaxis could mitigate this hazard; however, there are currently no evidence-based or consensus guidelines. This study surveyed UK and Republic of Ireland vascular consultants to determine areas of consensus.MethodsA 32-item survey was sent to vascular consultants via the Vascular and Endovascular Research Network (phase 1). These results generated 10 consensus statements which were redistributed (phase 2). ‘Good’ and ‘very good’ consensus were defined as endorsement/rejection of statements by >67% and >85% of respondents, respectively.ResultsForty-two consultants completed phase 1. This generated seven statements regarding risk factors mandating peri-procedural pharmacoprophylaxis and three statements regarding specific pharmacoprophylaxis regimes. Forty-seven consultants completed phase 2. Regarding venous thromboembolism risk factors mandating pharmacoprophylaxis, ‘good’ and ‘very good’ consensus was achieved for 5/7 and 2/7 statements, respectively. Regarding specific regimens, ‘very good’ consensus was achieved for 3/3 statements.ConclusionsThe main findings from this study were that there was ‘good’ or ‘very good’ consensus that patients with any of the seven surveyed risk factors should be given pharmacoprophylaxis with low-molecular-weight heparin. High-risk patients should receive one to two weeks of pharmacoprophylaxis rather than a single dose.
AU  - Dattani,N
AU  - Shalhoub,J
AU  - Nandhra,S
AU  - Lane,T
AU  - Abu-Own,A
AU  - Elbasty,A
AU  - Jones,A
AU  - Duncan,A
AU  - Garnham,A
AU  - Thapar,A
AU  - Murray,A
AU  - Baig,A
AU  - Saratzis,A
AU  - Sharif,A
AU  - Huasen,B
AU  - Dawkins,C
AU  - Nesbitt,C
AU  - Carradice,D
AU  - Morrow,D
AU  - Bosanquet,D
AU  - Kavanagh,E
AU  - Shaikh,F
AU  - Gosi,G
AU  - Ambler,G
AU  - Fulton,G
AU  - Singh,G
AU  - Travers,H
AU  - Moore,H
AU  - Olivier,J
AU  - Hitchman,L
AU  - O'Donohoe,M
AU  - Popplewell,M
AU  - Medani,M
AU  - Jenkins,M
AU  - Goh,MA
AU  - Lyons,O
AU  - McBride,O
AU  - Moxey,P
AU  - Stather,P
AU  - Burns,P
AU  - Forsythe,R
AU  - Sam,R
AU  - Brar,R
AU  - Brightwell,R
AU  - Benson,R
AU  - Onida,S
AU  - Paravastu,S
AU  - Lambracos,S
AU  - Vallabhaneni,SR
AU  - Walsh,S
AU  - Aktar,T
AU  - Moloney,T
AU  - Mzimba,Z
AU  - Nyamekye,I
DO  - 10.1177/0268355520936420
EP  - 714
PY  - 2020///
SN  - 0268-3555
SP  - 706
TI  - Reducing the risk of venous thromboembolism following superficial endovenous treatment: a UK and Republic of Ireland consensus study
T2  - Phlebology
UR  - http://dx.doi.org/10.1177/0268355520936420
UR  - http://hdl.handle.net/10044/1/80880
VL  - 35
ER  -

Download

DrTristanLane

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)